Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET
2005-01-01 Swedberg, K; Olsson, Lg; Charlesworth, A; Cleland, J; Hanrath, P; Komajda, M; Metra, Marco; Torp Pedersen, C; Poole Wilson, P.
Electrolyte disturbances in chronic heart failure: metabolic and clinical aspects
1995-01-01 Dei Cas, L; Metra, M.; Leier, C. V.
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
2007-01-01 Mcmurray, Jj; Teerlink, Jr; Cotter, G; Bourge, Rc; Cleland, Jg; Jondeau, G; Krum, H; Metra, Marco; O'Connor, Cm; Parker, Jd; Torre Amione, G; Van Veldhuisen, Dj; Lewsey, J; Frey, A; Rainisio, M; Kobrin, I.
Morphine in Acute Pulmonary Oedema: A Signal of Harm but More Questions Than Answers
2022-01-01 Chioncel, Ovidiu; Metra, Marco
Pulmonary hypertension and systemic hypotension as limitations to exercise in chronic heart failure
1994-01-01 Mabee, S. W.; Metra, Marco; Reed, D. E.; Cody, R. J.; Dei Cas, Livio
July 2016 at a glance: the critical role of co-morbidities
2016-01-01 Metra, Marco
Sagittal dentoskeletal modifications associated with different activation protocols of rapid maxillary expansion
2018-01-01 Baldini, A; Nota, A; Santariello, C; Caruso, S; Assi, V; Ballanti, F; Gatto, R; Cozza, P.
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program
2010-01-01 O'Connor, Cm; Miller, Ab; Blair, Je; Konstam, Ma; Wedge, P; Bahit, Mc; Carson, P; Haass, M; Hauptman, Pj; Metra, Marco; Oren, Rm; Patten, R; Piña, I; Roth, S; Sackner Bernstein, Jd; Traver, B; Cook, T; Gheorghiade, M.
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial
2016-01-01 Teerlink, John R; Felker, G Michael; Mcmurray, John J V; Solomon, Scott D; Adams, Kirkwood F; Cleland, John G F; Ezekowitz, Justin A; Goudev, Assen; Macdonald, Peter; Metra, Marco; Mitrovic, Veselin; Ponikowski, Piotr; Serpytis, Pranas; Spinar, Jindrich; Tomcsányi, János; Vandekerckhove, Hans J; Voors, Adriaan A; Monsalvo, Maria Laura; Johnston, James; Malik, Fady I; Honarpour, Narimon
Macro- and microvascular functions in cystic fibrosis adults without cardiovascular risk factors: A case-control study
2019-01-01 Vizzardi, E; Sciatti, E; Bonadei, I; Cani, Ds; Menotti, E; Prati, F; Dallapellegrina, L; Metra, M; Berlendis, M; Poli, P; Padoan, R
The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure
1991-01-01 Nodari, Savina; Metra, Marco; Gei, P; Danesi, R; Furloni, R; Cuminetti, S; Dei Cas, Livio
Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine
2015-01-01 Mebazaa, Alexandre; Yilmaz, M Birhan; Levy, Phillip; Ponikowski, Piotr; Peacock, W Frank; Laribi, Said; Ristic, Arsen D; Lambrinou, Ekaterini; Masip, Josep; Riley, Jillian P; Mcdonagh, Theresa; Mueller, Christian; Defilippi, Christopher; Harjola, Veli-Pekka; Thiele, Holger; Piepoli, Massimo F; Metra, Marco; Maggioni, Aldo; Mcmurray, John; Dickstein, Kenneth; Damman, Kevin; Seferovic, Petar M; Ruschitzka, Frank; Leite-Moreira, Adelino F; Bellou, Abdelouahab; Anker, Stefan D; Filippatos, Gerasimos
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment
2008-01-01 Cotter, G; Dittrich, Hc; Weatherley, Bd; Bloomfield, Dm; O'Connor, Cm; Metra, Marco; Massie, Bm; Protect Steering Committee, Investigators; Coordinators,
Cardiopulmonary stress test for the evaluation of therapeutic results in heart failure. Maximal or submaximal test?
1996-01-01 Dei Cas, Livio; Metra, Marco
Thrombotic risk in patients with COVID-19
2021-01-01 Pancaldi, Edoardo; Pascariello, Greta; Cimino, Giuliana; Cersosimo, Angelica; Amore, Ludovica; Alghisi, Fabio; Bernardi, Nicola; Calvi, Emiliano; Lombardi, Carlo Mario; Vizzardi, Enrico; Metra, Marco
Heart failure: should treatment favor prognosis or quality of life? Opinion... in favor of prognosis
2002-01-01 Metra, Marco; Nodari, Savina; Dei Cas, Livio
February 2017 at a glance: fibrosis, acute heart failure and neurologic abnormalities
2017-01-01 Metra, Marco
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study
2022-01-01 Vezzoli, Marika; Inciardi, Riccardo Maria; Oriecuia, Chiara; Paris, Sara; Murillo, Natalia Herrera; Agostoni, Piergiuseppe; Ameri, Pietro; Bellasi, Antonio; Camporotondo, Rita; Canale, Claudia; Carubelli, Valentina; Carugo, Stefano; Catagnano, Francesco; Danzi, Giambattista; Dalla Vecchia, Laura; Giovinazzo, Stefano; Gnecchi, Massimiliano; Guazzi, Marco; Iorio, Anita; La Rovere, Maria Teresa; Leonardi, Sergio; Maccagni, Gloria; Mapelli, Massimo; Margonato, Davide; Merlo, Marco; Monzo, Luca; Mortara, Andrea; Nuzzi, Vincenzo; Pagnesi, Matteo; Piepoli, Massimo; Porto, Italo; Pozzi, Andrea; Provenzale, Giovanni; Sarullo, Filippo; Senni, Michele; Sinagra, Gianfranco; Tomasoni, Daniela; Adamo, Marianna; Volterrani, Maurizio; Maroldi, Roberto; Metra, Marco; Lombardi, Carlo Mario; Specchia, Claudia
Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation
2021-01-01 Zaccone, Gregorio; Tomasoni, Daniela; Italia, Leonardo; Lombardi, Carlo Mario; Metra, Marco
Can Carbohydrate Antigen-125 Be a New Biomarker to Guide Heart Failure Treatment?: The CHANCE-HF Trial
2016-01-01 D'Aloia, Antonio; Vizzardi, Enrico; Metra, Marco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET | 1-gen-2005 | Swedberg, K; Olsson, Lg; Charlesworth, A; Cleland, J; Hanrath, P; Komajda, M; Metra, Marco; Torp Pedersen, C; Poole Wilson, P. | |
| Electrolyte disturbances in chronic heart failure: metabolic and clinical aspects | 1-gen-1995 | Dei Cas, L; Metra, M.; Leier, C. V. | |
| Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials | 1-gen-2007 | Mcmurray, Jj; Teerlink, Jr; Cotter, G; Bourge, Rc; Cleland, Jg; Jondeau, G; Krum, H; Metra, Marco; O'Connor, Cm; Parker, Jd; Torre Amione, G; Van Veldhuisen, Dj; Lewsey, J; Frey, A; Rainisio, M; Kobrin, I. | |
| Morphine in Acute Pulmonary Oedema: A Signal of Harm but More Questions Than Answers | 1-gen-2022 | Chioncel, Ovidiu; Metra, Marco | |
| Pulmonary hypertension and systemic hypotension as limitations to exercise in chronic heart failure | 1-gen-1994 | Mabee, S. W.; Metra, Marco; Reed, D. E.; Cody, R. J.; Dei Cas, Livio | |
| July 2016 at a glance: the critical role of co-morbidities | 1-gen-2016 | Metra, Marco | |
| Sagittal dentoskeletal modifications associated with different activation protocols of rapid maxillary expansion | 1-gen-2018 | Baldini, A; Nota, A; Santariello, C; Caruso, S; Assi, V; Ballanti, F; Gatto, R; Cozza, P. | |
| Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program | 1-gen-2010 | O'Connor, Cm; Miller, Ab; Blair, Je; Konstam, Ma; Wedge, P; Bahit, Mc; Carson, P; Haass, M; Hauptman, Pj; Metra, Marco; Oren, Rm; Patten, R; Piña, I; Roth, S; Sackner Bernstein, Jd; Traver, B; Cook, T; Gheorghiade, M. | |
| Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial | 1-gen-2016 | Teerlink, John R; Felker, G Michael; Mcmurray, John J V; Solomon, Scott D; Adams, Kirkwood F; Cleland, John G F; Ezekowitz, Justin A; Goudev, Assen; Macdonald, Peter; Metra, Marco; Mitrovic, Veselin; Ponikowski, Piotr; Serpytis, Pranas; Spinar, Jindrich; Tomcsányi, János; Vandekerckhove, Hans J; Voors, Adriaan A; Monsalvo, Maria Laura; Johnston, James; Malik, Fady I; Honarpour, Narimon | |
| Macro- and microvascular functions in cystic fibrosis adults without cardiovascular risk factors: A case-control study | 1-gen-2019 | Vizzardi, E; Sciatti, E; Bonadei, I; Cani, Ds; Menotti, E; Prati, F; Dallapellegrina, L; Metra, M; Berlendis, M; Poli, P; Padoan, R | |
| The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure | 1-gen-1991 | Nodari, Savina; Metra, Marco; Gei, P; Danesi, R; Furloni, R; Cuminetti, S; Dei Cas, Livio | |
| Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine | 1-gen-2015 | Mebazaa, Alexandre; Yilmaz, M Birhan; Levy, Phillip; Ponikowski, Piotr; Peacock, W Frank; Laribi, Said; Ristic, Arsen D; Lambrinou, Ekaterini; Masip, Josep; Riley, Jillian P; Mcdonagh, Theresa; Mueller, Christian; Defilippi, Christopher; Harjola, Veli-Pekka; Thiele, Holger; Piepoli, Massimo F; Metra, Marco; Maggioni, Aldo; Mcmurray, John; Dickstein, Kenneth; Damman, Kevin; Seferovic, Petar M; Ruschitzka, Frank; Leite-Moreira, Adelino F; Bellou, Abdelouahab; Anker, Stefan D; Filippatos, Gerasimos | |
| The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment | 1-gen-2008 | Cotter, G; Dittrich, Hc; Weatherley, Bd; Bloomfield, Dm; O'Connor, Cm; Metra, Marco; Massie, Bm; Protect Steering Committee, Investigators; Coordinators, | |
| Cardiopulmonary stress test for the evaluation of therapeutic results in heart failure. Maximal or submaximal test? | 1-gen-1996 | Dei Cas, Livio; Metra, Marco | |
| Thrombotic risk in patients with COVID-19 | 1-gen-2021 | Pancaldi, Edoardo; Pascariello, Greta; Cimino, Giuliana; Cersosimo, Angelica; Amore, Ludovica; Alghisi, Fabio; Bernardi, Nicola; Calvi, Emiliano; Lombardi, Carlo Mario; Vizzardi, Enrico; Metra, Marco | |
| Heart failure: should treatment favor prognosis or quality of life? Opinion... in favor of prognosis | 1-gen-2002 | Metra, Marco; Nodari, Savina; Dei Cas, Livio | |
| February 2017 at a glance: fibrosis, acute heart failure and neurologic abnormalities | 1-gen-2017 | Metra, Marco | |
| Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study | 1-gen-2022 | Vezzoli, Marika; Inciardi, Riccardo Maria; Oriecuia, Chiara; Paris, Sara; Murillo, Natalia Herrera; Agostoni, Piergiuseppe; Ameri, Pietro; Bellasi, Antonio; Camporotondo, Rita; Canale, Claudia; Carubelli, Valentina; Carugo, Stefano; Catagnano, Francesco; Danzi, Giambattista; Dalla Vecchia, Laura; Giovinazzo, Stefano; Gnecchi, Massimiliano; Guazzi, Marco; Iorio, Anita; La Rovere, Maria Teresa; Leonardi, Sergio; Maccagni, Gloria; Mapelli, Massimo; Margonato, Davide; Merlo, Marco; Monzo, Luca; Mortara, Andrea; Nuzzi, Vincenzo; Pagnesi, Matteo; Piepoli, Massimo; Porto, Italo; Pozzi, Andrea; Provenzale, Giovanni; Sarullo, Filippo; Senni, Michele; Sinagra, Gianfranco; Tomasoni, Daniela; Adamo, Marianna; Volterrani, Maurizio; Maroldi, Roberto; Metra, Marco; Lombardi, Carlo Mario; Specchia, Claudia | |
| Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation | 1-gen-2021 | Zaccone, Gregorio; Tomasoni, Daniela; Italia, Leonardo; Lombardi, Carlo Mario; Metra, Marco | |
| Can Carbohydrate Antigen-125 Be a New Biomarker to Guide Heart Failure Treatment?: The CHANCE-HF Trial | 1-gen-2016 | D'Aloia, Antonio; Vizzardi, Enrico; Metra, Marco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista38896
Data di pubblicazione
- In corso di stampa10
- 2020 - 202711075
- 2010 - 201915891
- 2000 - 20097438
- 1990 - 19993474
- 1980 - 1989930
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.775
- Elsevier B.V.749
- John Wiley and Sons Inc493
- Springer Science and Business Med...489
- Oxford University Press456
- Lippincott Williams and Wilkins406
- Springer350
- MDPI348
- Elsevier Ltd320
- Springer Nature256
Rivista
- EUROPEAN UROLOGY527
- BLOOD373
- PLOS ONE309
- EUROPEAN JOURNAL OF HEART FAILURE273
- JOURNAL OF NEUROLOGY273
- NEUROLOGY267
- DIGESTIVE AND LIVER DISEASE246
- EUROPEAN HEART JOURNAL222
- MULTIPLE SCLEROSIS212
- SCIENTIFIC REPORTS209
Keyword
- Humans3554
- Male2081
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- Retrospective Studies628
- COVID-19624
- Treatment Outcome603
- Prognosis475
Lingua
- eng28310
- ita1931
- fre64
- und55
- spa34
- ger25
- por12
- rus6
- grc3
- pol3
Accesso al fulltext
- no fulltext33709
- open3003
- reserved2090
- partially open82
- embargoed11
- mixed1